UnknownPhase 2NCT04927390
Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)
Studying Diffuse cutaneous systemic sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University College, London
- Principal Investigator
- Christopher DentonUniversity College, London
- Intervention
- Mycophenolate Mofetil 500mg(drug)
- Enrollment
- 120 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2024
Study locations (12)
- Royal United Hospitals Bath Nhs Foundation Trust, Bath, United Kingdom
- Southmead Hospital - NORTH BRISTOL NHS TRUST, Bristol, United Kingdom
- Darlington Memorial Hospital - County Durham and Darlington NHS Foundation Trust, Darlington, United Kingdom
- Ninewells Hospital - NHS Tayside, Dundee, United Kingdom
- Chapel Allerton Hospital - LEEDS TEACHING HOSPITALS NHS TRUST, Leeds, United Kingdom
- Aintree University Hospital NHS Foundation Trust, Liverpool, United Kingdom
- Royal Free Hospital - Royal Free NHS Foundation Trust, London, United Kingdom
- Manchester Royal Infirmary - Manchester University NHS Foundation Trust, Manchester, United Kingdom
- Salford Hospital - Northern Care Alliance NHS Foundation Trust, Manchester, United Kingdom
- Freeman Hospital - THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST, Newcastle, United Kingdom
- Royal Hallamshire Hospital - SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST, Sheffield, United Kingdom
- The Royal Wolverhampton Nhs Trust, Wolverhampton, United Kingdom
Collaborators
Versus Arthritis
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04927390 on ClinicalTrials.govOther trials for Diffuse cutaneous systemic sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07473154Controlling Hyperactive Immunity With Long-lived LymphocytesQuell Therapeutics Limited
- RECRUITINGPHASE1, PHASE2NCT06947473Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.Beijing GoBroad Hospital
- RECRUITINGPHASE2NCT05029336Autologous Stem Cell Transplant (ASCT) for Autoimmune DiseasesStephan Grupp MD PhD
- RECRUITINGPHASE2NCT07047690A Study of Nemolizumab for the Treatment of Adults With Systemic SclerosisGalderma R&D
- RECRUITINGPHASE2NCT07287670EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)Mediar Therapeutics
- RECRUITINGNCT07256418Transcriptomic Study of Cutaneous Fibroblasts in SclerodermaCentre Hospitalier Universitaire Dijon
- RECRUITINGPHASE1NCT07295847A Study of AZD0120 in Autoimmune DiseasesAstraZeneca
- RECRUITINGNANCT07292961Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With SclerodermaHacettepe University